Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

442 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095. Health Aff (Millwood). 2006. PMID: 16835191
We use it as a case study to assess how FDA standards for drug approval, marketing practices by drug manufacturers, and physicians' prescribing choices can shape the risk-benefit relationship of new drugs. ...
We use it as a case study to assess how FDA standards for drug approval, marketing practices by drug manufacturers, and physicians' p …
Rethinking global access to vaccines.
Chokshi DA, Kesselheim AS. Chokshi DA, et al. BMJ. 2008 Apr 5;336(7647):750-3. doi: 10.1136/bmj.39497.598044.BE. BMJ. 2008. PMID: 18390526 Free PMC article.
Barriers to dissemination of life saving vaccines in low income countries can and should be overcome, argue Dave Chokshi and Aaron Kesselheim...
Barriers to dissemination of life saving vaccines in low income countries can and should be overcome, argue Dave Chokshi and Aaron Kessel
The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients.
Kesselheim AS, Choudhry NK. Kesselheim AS, et al. Ann Intern Med. 2008 Apr 15;148(8):614-9. doi: 10.7326/0003-4819-148-8-200804150-00006. Ann Intern Med. 2008. PMID: 18413623
As patient use of foreign-bought drugs has increased, federal legislators have continued to debate the full legalization of importation. Three factors help guide whether U.S. patients and policymakers can rely on other countries as sources of imported prescription d
As patient use of foreign-bought drugs has increased, federal legislators have continued to debate the full legalization of importati
Drug development for neglected diseases - the trouble with FDA review vouchers.
Kesselheim AS. Kesselheim AS. N Engl J Med. 2008 Nov 6;359(19):1981-3. doi: 10.1056/NEJMp0806684. N Engl J Med. 2008. PMID: 18987367 No abstract available.
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.
For editorials, we categorized authors' positions on generic substitution as negative, positive, or neutral. RESULTS: We identified 47 articles covering 9 subclasses of cardiovascular medications, of which 38 (81%) were randomized controlled trials (RCTs). ...
For editorials, we categorized authors' positions on generic substitution as negative, positive, or neutral. RESULTS: We identified 4 …
The Supreme Court, preemption, and malpractice liability.
Kesselheim AS, Studdert DM. Kesselheim AS, et al. N Engl J Med. 2009 Feb 5;360(6):559-61. doi: 10.1056/NEJMp0809403. N Engl J Med. 2009. PMID: 19196672 No abstract available.
442 results
Jump to page
Feedback